EGFR-HER2 inhibitor WHI-P180, Purity ≥98%

Cat. No.: X24-05-ZQ655

EGFR-HER2 inhibitor WHI-P180, Purity ≥98%

Synonym: 211555-08-7; Janex 3; WHI-P 180; EGFR-HER2 inhibitor

  • CAS Number: 211555-08-7
  • Compound CID: 5687
Product Size
5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
WHI-P180, soluble in DMSO and insoluble in ethanol and water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR, KDR, and RET.
Molecular Weight
297.31
Molecular Formula
C16H15N3O3
Targets
EGFR: 4 μM; KDR: 66 nM; RET: 5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 51 mg/mL (171.53 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
WHI-P180 is utilized in studies targeting EGFR inhibition and its impact on cancer cell signaling.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.